An efficient, food contact accelerator for stereocomplexation of high-molecular-weight poly(l
-
Add time:08/10/2019 Source:sciencedirect.com
It is an effective strategy to improve the heat resistance of polylactide (PLA) via forming stereocomplex crystals (SCs) in poly(l-lactide) (PLLA)/poly(d-lactide) (PDLA) blend. In this work, pentearythritol (PENTA), which is an environment-friendly polyhydroxy compound for food packaging, is selected to facilitate the SC crystallization and suppress the HC crystallization for HMW PLLA/PDLA blend. Impressively, only 3 wt% PENTA is added, the exclusive SCs with high content (Xc,SC = 50%) can be obtained, which exhibits a high promotion efficiency of crystallization of SCs. Interestingly, with PENTA content ascending, the crystallinity of SCs increases drastically first and then in a relatively slow manner. Furthermore, Miscibility with high content of PENTA leads to a relatively looser packing of SC lamella in the blend confirmed by scanning electron microscope (SEM) due to intercalation of PENTA between crystal lamella. The mechanism of how PENTA facilitates the formation of SCs at molecular level is also proposed in this work.
We also recommend Trading Suppliers and Manufacturers of POLY(D-LACTIDE) (cas 106989-11-1). Pls Click Website Link as below: cas 106989-11-1 suppliers
Prev:Enhanced crystallization kinetics of symmetric poly(l
Next:Electrospun, drug-enriched bioresorbable nonwovens based on poly(glycolide-ɛ-caprolactone) and poly(d) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Poly(L-lactide) nanocomposites containing poly(D-lactide) grafted nanohydroxyapatite with improved interfacial adhesion via stereocomplexation08/14/2019
- Real-time monitoring of stereocomplex formation of poly(l08/13/2019
- Performance evaluation of poly (l08/12/2019
- Electrospun, drug-enriched bioresorbable nonwovens based on poly(glycolide-ɛ-caprolactone) and poly(d08/11/2019
- Enhanced crystallization kinetics of symmetric poly(l08/09/2019
- Effects of molten poly(d08/08/2019
- Ivermectin controlled release implants based on poly-D,l08/07/2019


